Frank Jaksch

Frank Jaksch is the Chief Executive Officer of Ayana Bio, a position he has held since July 2022.2 He is a veteran in the health and wellness industry with over 25 years of experience in life sciences and consumer products, particularly in the areas of food, beverages, and dietary supplements.12

Career Highlights

Ayana Bio: As CEO of Ayana Bio, Jaksch leads a company that focuses on producing sustainable bioactives for health and wellness products using plant cell cultivation rather than traditional agriculture.13 The company aims to address challenges in the ingredient supply chain by providing standardized, high-quality plant bioactives without the limitations of agricultural production.3

ChromaDex: Prior to joining Ayana Bio, Jaksch was the founder and longtime CEO of ChromaDex, a Nasdaq-listed company (NASDAQ: CDXC).23 He currently serves as the Chairman of the Board at ChromaDex, which he co-founded in September 1999.2 ChromaDex is known for its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®.2

Other Roles and Expertise

• Advisory Board Member at Yuva Biosciences, Inc. since September 20192
• Board Member of the Natural Products Association since September 20132
• Recognized global expert on natural products chemistry, longevity, and healthspan3

Education

Jaksch attended Valparaiso University.2

Vision and Approach

Frank Jaksch is passionate about revolutionizing the health and wellness sector by providing affordable and reliable ingredients.1 He believes that Ayana Bio's technology platform is key to developing scientific solutions to reliability and cost issues in the industry.1 Jaksch aims to modernize the production of plant bioactives, addressing challenges such as supply chain issues, climate change impacts, and quality control in the botanicals industry.3